{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:07:47Z","timestamp":1761577667857,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["IUT34-24","PUT1580"],"award-info":[{"award-number":["IUT34-24","PUT1580"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003510","name":"Haridus- ja Teadusministeerium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.meegid.2019.05.019","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T20:49:48Z","timestamp":1558990188000},"page":"103901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Stable level of HIV transmitted drug resistance in Estonia despite significant scale-up of antiretroviral therapy"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1445-7653","authenticated-orcid":false,"given":"Pilleriin","family":"Soodla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Huik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merit","family":"Pauskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9433-8752","authenticated-orcid":false,"given":"Lize","family":"Cuypers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristel","family":"Van Laethem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heli","family":"Rajasaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveli","family":"Kallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Lepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Velts-Lindh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ene-Ly","family":"J\u00f5geda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irja","family":"Lutsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radko","family":"Avi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.meegid.2019.05.019_bb0005","first-page":"598","article-title":"Predominance of a rare type of HIV-1 in Estonia","volume":"39","author":"Adojaan","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"6","key":"10.1016\/j.meegid.2019.05.019_bb0010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/jmv.21482","article-title":"Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia","volume":"81","author":"Avi","year":"2009","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.meegid.2019.05.019_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/00365548.2010.526956","article-title":"Emerging transmitted drug resistance in treatment-naive human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia","volume":"43","author":"Avi","year":"2011","journal-title":"Scand. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.meegid.2019.05.019_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/aid.2012.0357","article-title":"Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010","volume":"30","author":"Avi","year":"2014","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"3","key":"10.1016\/j.meegid.2019.05.019_bb0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/aid.2012.0357","article-title":"Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010","volume":"30","author":"Avi","year":"2014","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"12","key":"10.1016\/j.meegid.2019.05.019_bb0030","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/jmv.21921","article-title":"Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia","volume":"82","author":"Balode","year":"2010","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.meegid.2019.05.019_bb0035","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/QAI.0b013e31817ae5c0","article-title":"Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA study","volume":"48","author":"Bannister","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"9839","key":"10.1016\/j.meegid.2019.05.019_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(12)60821-6","article-title":"Global epidemiology of HIV infection in men who have sex with men","volume":"380","author":"Beyrer","year":"2012","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.meegid.2019.05.019_bb0045","first-page":"204","article-title":"Current status of HIV-1 diversity and drug resistance monitoring in the former USSR","volume":"15","author":"Bobkova","year":"2013","journal-title":"AIDS Rev."},{"issue":"4","key":"10.1016\/j.meegid.2019.05.019_bb0050","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1089\/aid.2012.0312","article-title":"Distinct HIV type 1 strains in different risk groups and the absence of new infections by drug-resistant strains in Lithuania","volume":"29","author":"Caplinskas","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.meegid.2019.05.019_bb9041","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"Blast+: Architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"10.1016\/j.meegid.2019.05.019_bb0055","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1071\/SH16190","article-title":"Analysis of transmitted HIV drug resistance from 2005 to 2015 in Victoria, Australia: a comparison of the old and the new","volume":"14","author":"D'Costa","year":"2017","journal-title":"Sex. Health"},{"issue":"11","key":"10.1016\/j.meegid.2019.05.019_bb0060","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/jac\/dkt238","article-title":"National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011","volume":"68","author":"Descamps","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2019.05.019_bb9042","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2105-5-113","article-title":"Muscle: A multiple sequence alignment method with reduced time and space complexity","volume":"5","author":"Edgar","year":"2004","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.meegid.2019.05.019_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix499","article-title":"A phylogenetic analysis of HIV-1 sequences in Kiev: findings among key populations","author":"Fearnhill","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.meegid.2019.05.019_bb0070","first-page":"1127","article-title":"Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world","volume":"65","author":"Frentz","year":"2012","journal-title":"AIDS Rev."},{"key":"10.1016\/j.meegid.2019.05.019_bb0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/1471-2334-14-407","article-title":"Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe","volume":"14","author":"Frentz","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.meegid.2019.05.019_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/03008870310009597","article-title":"Epidemiological aspects of transmitted HIV drug resistance","volume":"106","author":"Girardi","year":"2003","journal-title":"Scand. J. Infect. Dis. Suppl."},{"issue":"9","key":"10.1016\/j.meegid.2019.05.019_bb9142","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/QAD.0000000000001470","article-title":"Defining HIV-1 transmission clusters based on sequence data","volume":"31","author":"Hassan","year":"2017","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.meegid.2019.05.019_bb0085","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.2.30436","article-title":"National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014","volume":"22","author":"Hauser","year":"2017","journal-title":"Euro Surveill."},{"issue":"5","key":"10.1016\/j.meegid.2019.05.019_bb0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cid\/civ963","article-title":"Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe","volume":"62","author":"Hofstra","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.meegid.2019.05.019_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033484","article-title":"Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010","volume":"7","author":"Karlsson","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.meegid.2019.05.019_bb0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.21101\/cejph.a3473","article-title":"HIV drug resistance tendencies in Latvia","volume":"16","author":"Kolupajeva","year":"2008","journal-title":"Cent. Eur. J. Public Health"},{"issue":"2","key":"10.1016\/j.meegid.2019.05.019_bb0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1468-1293.2009.00747.x","article-title":"Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment","volume":"11","author":"Murillo","year":"2010","journal-title":"HIV Med."},{"issue":"9947","key":"10.1016\/j.meegid.2019.05.019_bb0110","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(14)60844-8","article-title":"Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Murray","year":"2014","journal-title":"Lancet."},{"issue":"13","key":"10.1016\/j.meegid.2019.05.019_bb0115","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.meegid.2019.05.019_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12916-018-1241-1","article-title":"HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors","volume":"17","author":"Paraskevis","year":"2019","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.meegid.2019.05.019_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101738","article-title":"Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic","volume":"9","author":"Pineda-Pena","year":"2014","journal-title":"PLoS One"},{"author":"Ravimiamet","key":"10.1016\/j.meegid.2019.05.019_bb0130"},{"issue":"4","key":"10.1016\/j.meegid.2019.05.019_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"Rhee","year":"2015","journal-title":"PLoS Med."},{"issue":"15","key":"10.1016\/j.meegid.2019.05.019_bb0140","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.15.21094","article-title":"Internet-based recruitment system for HIV and STI screening for men who have sex with men in Estonia, 2013: analysis of preliminary outcomes","volume":"20","author":"Ruutel","year":"2015","journal-title":"Euro Surveill."},{"issue":"44","key":"10.1016\/j.meegid.2019.05.019_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005257","article-title":"Correlates of infection and molecular characterization of blood-borne HIV, HCV, and HBV infections in HIV-1 infected inmates in Italy: an observational cross-sectional study","volume":"95","author":"Sanarico","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.meegid.2019.05.019_bb0150","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/aid.2013.0262","article-title":"Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis","volume":"30","author":"Snedecor","year":"2014","journal-title":"AIDS Res. Hum. Retrovir."},{"year":"2015","series-title":"EACS Guidelines version 8.0","author":"Society EAC","key":"10.1016\/j.meegid.2019.05.019_bb0155"},{"issue":"11","key":"10.1016\/j.meegid.2019.05.019_bb0160","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3109\/23744235.2015.1061203","article-title":"Design and structure of the Estonian HIV Cohort Study (E-HIV)","volume":"47","author":"Soodla","year":"2015","journal-title":"Infect. Dis. (Lond)."},{"issue":"1","key":"10.1016\/j.meegid.2019.05.019_bb0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/hiv.12535","article-title":"HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay","volume":"19","author":"Soodla","year":"2017","journal-title":"HIV Med."},{"key":"10.1016\/j.meegid.2019.05.019_bb0170","unstructured":"State Agency of Medicines [04.04.2018]. Available from: https:\/\/www.ravimiamet.ee\/en."},{"issue":"5","key":"10.1016\/j.meegid.2019.05.019_bb0180","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ijid.2008.10.008","article-title":"Understanding transmitted HIV resistance through the experience in the USA","volume":"13","author":"Taiwo","year":"2009","journal-title":"Int. J. Infect. Dis."},{"year":"2013","series-title":"R: A Language and Environment for Statistical Computing","author":"Team RC","key":"10.1016\/j.meegid.2019.05.019_bb0185"},{"issue":"3","key":"10.1016\/j.meegid.2019.05.019_bb0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/hiv.12414","article-title":"Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom","volume":"18","author":"Tostevin","year":"2017","journal-title":"HIV Med."},{"issue":"1","key":"10.1016\/j.meegid.2019.05.019_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/088922201750056816","article-title":"Epidemiology of HIV in Estonia","volume":"17","author":"Ustina","year":"2001","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"8","key":"10.1016\/j.meegid.2019.05.019_bb0200","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283388742","article-title":"Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006","volume":"24","author":"Wheeler","year":"2010","journal-title":"Aids."},{"issue":"11","key":"10.1016\/j.meegid.2019.05.019_bb0205","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1089\/aid.2004.20.1148","article-title":"Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia","volume":"20","author":"Zetterberg","year":"2004","journal-title":"AIDS Res. Hum. Retrovir."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134819300966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134819300966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:41:15Z","timestamp":1761576075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134819300966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":43,"alternative-id":["S1567134819300966"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2019.05.019","relation":{},"ISSN":["1567-1348"],"issn-type":[{"type":"print","value":"1567-1348"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stable level of HIV transmitted drug resistance in Estonia despite significant scale-up of antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2019.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103901"}}